The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colombo, M. P.
Right arrow Articles by Parmiani, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, M. P.
Right arrow Articles by Parmiani, G.

The Journal of Immunology, Vol 149, Issue 1 113-119, Copyright © 1992 by American Association of Immunologists


ARTICLES

Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF- nonproducing tumor cells

MP Colombo, L Lombardi, A Stoppacciaro, C Melani, M Parenza, B Bottazzi and G Parmiani
Division of Experimental Oncology D, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.

We have previously demonstrated that the murine colon adenocarcinoma C- 26 cell line transduced with the human gene for the granulocyte CSF (G- CSF) loses tumorigenic activity through a mechanism that involved massive targeting of neutrophils at the site of tumor injection. The suppression of tumorigenicity by G-CSF was limited to the G-CSF- producing cells and was not transferred to nonproducing C-26 cells in a mixed tumor transplantation assay. We present direct evidence that neutrophils are involved in this phenomenon. We firstly examined, by electron microscopy (EM), the morphology of tumor infiltrates obtained 2, 5, and 10 days after s.c. injection of a mixture of G-CSF-producing and -nonproducing C-26 cells into syngeneic BALB/c mice. The EM analysis showed at 5, but not at 2 or 10 days, the presence of neutrophils in intimate contact with tumor cells. We then investigated whether neutrophils discriminate between G-CSF-producing and - nonproducing C-26 cells. To this aim, C-26 cells were transduced, via retroviral vector, with the Escherichia coli LacZ gene and mixed tumor transplantation assays were performed by injecting a mixture of G-CSF- producing beta-gal- and G-CSF-nonproducing beta-gal+ C-26 cells at different ratios. Histologic and EM analysis of the tumors growing at the site of injection were carried out. Five days after injection, treatment with x-gal revealed, at the histochemical level, the presence of neutrophils around G-CSF producing beta-gal- cells; cell-cell contacts and fusion of cell membranes were detected by EM only between neutrophils and G-CSF-producing cells. In vitro experiments, performed in Boyden chambers, confirmed that the G-CSF produced by C-26 cells was a chemoattractant for neutrophils. In addition, a colorimetric, cytostatic assay revealed that neutrophils were able to inhibit the growth of G-CSF-producing but not of G-CSF-nonproducing C-26 cells. Thus the tumor take after injection of G-CSF-producing C-26 cells seems to be controlled in situ through two major mechanisms namely neutrophil chemotaxis and neutrophil-mediated tumor inhibition. The results indicate that neutrophils can discriminate between G-CSF-producing and - nonproducing tumor cells and that neutrophils infiltrate the tumor mixture as long as G-CSF-producing cells are present.


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
T. Yamano, E. Morii, J.-I. Ikeda, and K. Aozasa
Granulocyte Colony-stimulating Factor Production and Rapid Progression of Gastric Cancer after Histological Change in the Tumor
Jpn. J. Clin. Oncol., October 1, 2007; 37(10): 793 - 796.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Okazaki, S. Ebihara, M. Asada, A. Kanda, H. Sasaki, and M. Yamaya
Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models
Int. Immunol., January 1, 2006; 18(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Grote, R. Cattaneo, and A. K. Fielding
Neutrophils Contribute to the Measles Virus-induced Antitumor Effect: Enhancement by Granulocyte Macrophage Colony-stimulating Factor Expression
Cancer Res., October 1, 2003; 63(19): 6463 - 6468.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. B. van Spriel, H. H. van Ojik, A. Bakker, M. J. H. Jansen, and J. G. J. van de Winkel
Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma
Blood, January 1, 2003; 101(1): 253 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Cairns, J. R. Gordon, F. Li, M. E. Baca-Estrada, T. Moyana, and J. Xiang
Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor
J. Immunol., July 1, 2001; 167(1): 57 - 65.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Di Carlo, G. Forni, P. Lollini, M. P. Colombo, A. Modesti, and P. Musiani
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
Blood, January 15, 2001; 97(2): 339 - 345.
[Full Text] [PDF]


Home page
J. Immunol.Home page
E. Di Carlo, A. Comes, S. Basso, A. De Ambrosis, R. Meazza, P. Musiani, K. Moelling, A. Albini, and S. Ferrini
The Combined Action of IL-15 and IL-12 Gene Transfer Can Induce Tumor Cell Rejection Without T and NK Cell Involvement
J. Immunol., September 15, 2000; 165(6): 3111 - 3118.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Vicari, S. Ait-Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
J. Immunol., August 15, 2000; 165(4): 1992 - 2000.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Tagliabue, F. Castiglioni, C. Ghirelli, M. Modugno, L. Asnaghi, G. Somenzi, C. Melani, and S. Menard
Nerve Growth Factor Cooperates with p185HER2 in Activating Growth of Human Breast Carcinoma Cells
J. Biol. Chem., February 25, 2000; 275(8): 5388 - 5394.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Shimizu, A. Fontana, Y. Takeda, H. Yagita, T. Yoshimoto, and A. Matsuzawa
Induction of Antitumor Immunity with Fas/APO-1 Ligand (CD95L)-Transfected Neuroblastoma Neuro-2a Cells
J. Immunol., June 15, 1999; 162(12): 7350 - 7357.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Fioretti, D. Fradelizi, A. Stoppacciaro, S. Ramponi, L. Ruco, A. Minty, S. Sozzani, C. Garlanda, A. Vecchi, and A. Mantovani
Reduced Tumorigenicity and Augmented Leukocyte Infiltration After Monocyte Chemotactic Protein-3 (MCP-3) Gene Transfer: Perivascular Accumulation of Dendritic Cells in Peritumoral Tissue and Neutrophil Recruitment Within the Tumor
J. Immunol., July 1, 1998; 161(1): 342 - 346.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Noffz, Z. Qin, M. Kopf, and T. Blankenstein
Neutrophils but Not Eosinophils Are Involved in Growth Suppression of IL-4-Secreting Tumors
J. Immunol., January 1, 1998; 160(1): 345 - 350.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Gojo, S. Kitamura, O. Hatano, A. Takakusu, K. Hashimoto, Y. Kanegae, and I. Saito
TRANSPLANTATION OF GENETICALLY MARKED CARDIAC MUSCLE CELLS
J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 10 - 18.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.